21/01/2026
Big News from Firebrick Pharma (ASX:FRE) 🚀 We are thrilled to announce that our new product—Nasodine® Throat Spray—has officially launched in Singapore! 🇸🇬 Following successful manufacturing in Australia and shipment earlier this month, this launch marks a significant milestone in our international expansion. 🌍
Why it matters:
âś… Comprehensive care: Nasodine Throat Spray (1% povidone-iodine) complements our existing Nasal Spray, providing dual "nasal and oral" defence against the germs that cause colds and flu.
âś… Strategic rollout: Partnering with Innorini Life Sciences, the initial 6-month focus will be on hospitals and healthcare professionals (HCPs) before hitting retail shelves in Singapore.
✅ The convenience of the throat spray should a major benefit in the Singapore market; it’s perfect for travel, commuting, and other on-the-go uses.
